Skip to content

Global Event Activations – October 2024

Event Announcement 3 (1)
 

Look out for Team Mass Dynamics!

At one of many key global events through October, keep an eye out for our team members who are brimming with anticipation to hear all about your latest work, insights, challenges, achievements, and discoveries. 

Drop by at one of TPD Summit in Boston, HUPO Congress in Dresden or Advances in Mass Spectrometry Enabled Drug Discovery in Stanford to say HI, or reach out to them directly for a chat.

Paula Burton

Paula Burton

CEO, Co-founder

Visit twitter Visit linkedin
Andrew Webb

Assoc. Prof. Andrew Webb

Chief Scientist , Co-founder

Visit twitter Visit linkedin
Guiseppe Infusini

Giuseppe Infusini

Proteomics Bioinformatics Lead, Co-founder

Visit linkedin
Mark Condina

Mark Condina, Ph.D

Research Collaboration Lead

Visit twitter Visit linkedin
Anna Quaglieri

Anna Quaglieri, Ph.D

Senior Bioinformatics Data Scientist

Visit twitter Visit linkedin
 

Human Proteome Organization Conference (HUPO), Dresden

IMG_6531-1

Ask Anna how leveraging Mass Dynamics 2.0 can support proteomics-based biomarker discovery
 

Anna Quaglieri, Ph.D,  Mass Dynamics,  Senior Bioinformatics Data Scientist
Poster Presentation: Wednesday, 23rd October, 1.00pm - 3.00pm (CEST)
 
Typical proteomics-based Biomarker discovery approaches aim to define a small subset of biological markers able to predict biological groups of interest. While biomarker discovery spans a broad range of applications, a key use is the detection of markers able to signal the early onset of a disease, increasing the potential to inform and highly improve the treatment of patients.
 
Poster P-III-0822 in Group - Data Integration: With Bioinformatics to Biological Knowledge
IMG_8431 (1)
Early Career Researcher (ECR) 3-Minute Thesis Competition
 
Co-Chairs: Isabell Bludau (University Hospital Heidelberg) and Paula Burton (Mass Dynamics)
Session: Monday, 21st October, 3.15pm - 4.20pm (CEST), Rooms 3-4 
 
Mass Dynamics is proud to sponsor the HUPO Early Career Researcher (ECR) 3-minute thesis competition where candidates will present their research within 3 minutes using one static slide and in a form that can be understood by a general audience. 
 
IMG_8184
Sponsoring 'Empowerment Award' at FeMS+ and Moms in Proteomics Networking Event
 
Topic: Leveraging Our Power: FeMS+ and Moms in Proteomics Networking Event
Session: Tuesday, 22nd October, 12pm - 2pm (CEST)
 
We are proud to sponsor the Empowerment Award at this year’s networking event, hosted by Moms in Proteomics and Females in Mass Spectrometry. This award celebrates individuals who are driving positive change, inspiring collaboration, and empowering the next generation of scientists in proteomics. Join us as we honor those making a meaningful impact in the community.
 
 

Targeted Protein Degradation Summit (TPD), Boston

MD Private Meeting

Exhibition Booth and Custom Demo Meetings

 

Monday 28th October - Thursday 31st, (EST)
The Westin Copley Place, Boston
 

We look forward to hosting you and your team in private 30-minute meetings specifically designed to learn more about how you're addressing the unique challenges of leveraging proteomics for your degrader programs.

We will also share and demo how our secure, scalable and integrated platform is helping our customers gain significant advantage by transforming intimidating omics data into actionable knowledge through advanced visualizations, sharing, and collaboration.

Request a meeting

IMG_2406
Ask Giuseppe how leveraging Mass Dynamics 2.0 can support targeted protein degradation workflows
 
Giuseppe Infusini, Ph.D,  Mass Dynamics,  Proteomics Informatics Lead
Poster Presentation: TBA
 
Targeted Protein Degradation (TPD) workflows are transforming drug discovery by enabling the selective degradation of disease-causing proteins. However, optimizing TPD workflows requires robust data integration, from initial proteomics experiments to validation across independent datasets. Success hinges on seamless experimental design, data management, and reproducibility to ensure meaningful insights for therapeutic development.
 

Learn more about Mass Dynamics

 
We look forward to connecting!